Overview:
Tropical diseases are the infectious diseases that thrive in the hot and humid climatic conditions, which is suitable for the growth of micro-organisms like parasites, fungi, bacteria and virus. The population of vectors like mosquitos and insects also thrive which transmit disease pathogens. A large number of lives can be saved if they are diagnosed early and medical interventions are taken accordingly. The major factorial entities supporting the growth in demand for tropical disease diagnostic market are rise in population of tropical countries, increasing prevalence rate of neglected tropical diseases, access to healthcare services and government intervention. Due to high population rate, poverty, lack of sanitation and potable water the tropical disease has a high prevalence and incident rate in the tropical countries. Increasing prevalence of neglected tropical diseases like Chagas disease, Schistosomiasis are as a result of living in close contact with infectious vectors, domestic animals, and livestock.
Government agencies are investing to provide better diagnostic services and arranging healthcare campaigns at several healthcare centers in both the urban and remote areas, a huge amount is also spent to provide better socio-economic services. However, the challenges in this scenario would be the limited number of trained healthcare professionals with the proficiency to diagnose and interpret the tropical infectious diseases by techniques like RT- PCR, immunoassay, hematology etc. The patients located in the remote areas cannot get access to diagnosis and treatment of tropical diseases. Restraints regarding the tropical disease diagnostic market are ambiguous reimbursement policies, low illiteracy rate and lack of skilled personnel. Poverty and gross negligence is the biggest hurdle as it leads to low disease awareness where patient is unaware that diseases like Tuberculosis, Diphtheria and Hepatitis can be cured and diseases like HIV, Gonorrhea and other sexually transmitted diseases can be safely monitored by early diagnosis.
In Asia-Pacific and Middle East there is wide prevalence of tropical diseases as the disease awareness is high the patients undergo early diagnosis and treatment. Latin America and Africa are potential markets due to high prevalence of tropical diseases. The unmet medical needs in the remote areas can be captured as potential market
Manufacturers like Agilent Technologies, Becton Dickinson and Company, Abbot Laboratories have come with innovative diagnostic techniques like clinical flow cytometry, immunoassay, rapid diagnostic assay which is helpful in early diagnosis of life threatening diseases like Zika virus, Ebola, Swine flu which requires immediate medical intervention. Beckman Coulter, Sysmex Corporation are involved in the hematology and blood banking devices which are helpful in the diagnosis and prevention of diseases like Hepatitis, Giardiasis and other blood transfusion diseases. The latest trends in the tropical disease diagnosis are the immunochromatographic devices, Real time PCR are being optimized for better results.
The global tropical disease diagnostic market is segmented on the following bases:
Key players identified for global tropical disease diagnostic market include:
The major players involved in global tropical disease diagnostic market are Abbott diagnostics, Agilent technologies, Alere, Beckman Coulter, Inc./Danaher, Becton, Dickinson and company (BD), BioMérieux Inc., Bio-Rad laboratories, Boditech Med Inc. Johnson and Johnson, Roche Diagnostics, Siemens healthcare, Sysmex corporation.
This report offers:
